Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
03
06
2020
accepted:
27
07
2020
pubmed:
5
8
2020
medline:
27
11
2020
entrez:
5
8
2020
Statut:
epublish
Résumé
The severe acute respiratory syndrome-coronavirus 2 outbreak spread rapidly in Italy and the lack of intensive care unit (ICU) beds soon became evident, forcing the application of noninvasive respiratory support (NRS) outside the ICU, raising concerns over staff contamination. We aimed to analyse the safety of the hospital staff and the feasibility and outcomes of NRS applied to patients outside the ICU. In this observational study, data from 670 consecutive patients with confirmed coronavirus disease 2019 referred to pulmonology units in nine hospitals between March 1 and May 10, 2020 were analysed. Data collected included medication, mode and usage of NRS ( 42 (11.1%) healthcare workers tested positive for infection, but only three of them required hospitalisation. Data are reported for all patients (69.3% male), whose mean±sd age was 68±13 years. The arterial oxygen tension/inspiratory oxygen fraction ratio at baseline was 152±79, and the majority (49.3%) of patients were treated with CPAP. The overall unadjusted 30-day mortality rate was 26.9%, with 16%, 30% and 30% for HFNC, CPAP and NIV, respectively, while the total ETI rate was 27%, with 29%, 25% and 28%, respectively; the relative probability of death was not related to the NRS used after adjustment for confounders. ETI and length of stay were not different among the groups. Mortality rate increased with age and comorbidity class progression. The application of NRS outside the ICU is feasible and associated with favourable outcomes. Nonetheless, it was associated with a risk of staff contamination.
Identifiants
pubmed: 32747398
pii: 13993003.02130-2020
doi: 10.1183/13993003.02130-2020
pmc: PMC7397952
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright ©ERS 2020.
Déclaration de conflit d'intérêts
Conflict of interest: C. Franco has nothing to disclose. Conflict of interest: N. Faccialongo has nothing to disclose. Conflict of interest: R. Tonelli has nothing to disclose. Conflict of interest: R. Dongilli has nothing to disclose. Conflict of interest: A. Vianello has nothing to disclose. Conflict of interest: L. Pisani has nothing to disclose. Conflict of interest: R. Scala has nothing to disclose. Conflict of interest: M. Malerba has nothing to disclose. Conflict of interest: A. Carlucci has nothing to disclose. Conflict of interest: E.A. Negri has nothing to disclose. Conflict of interest: G. Spoladore has nothing to disclose. Conflict of interest: G. Arcaro has nothing to disclose. Conflict of interest: P.A. Tillio has nothing to disclose. Conflict of interest: C. Lastoria has nothing to disclose. Conflict of interest: G. Schifino has nothing to disclose. Conflict of interest: L. Tabbì has nothing to disclose. Conflict of interest: L. Guidelli has nothing to disclose. Conflict of interest: G. Guaraldi has nothing to disclose. Conflict of interest: V.M. Ranieri has nothing to disclose. Conflict of interest: E. Clini has nothing to disclose. Conflict of interest: S. Nava has nothing to disclose.
Références
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JAMA. 2020 Apr 28;323(16):1612-1614
pubmed: 32191259
Eur Respir J. 2020 Jun 4;55(6):
pubmed: 32366488
J Crit Care. 2018 Dec;48:178-182
pubmed: 30216936
Eur Respir Rev. 2020 Apr 3;29(155):
pubmed: 32248146
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32430410
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
N Engl J Med. 2020 Jun 4;382(23):2267-2268
pubmed: 32294342
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434
pubmed: 32267160
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812